Affordable Access

Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL.

Authors
  • Di Costanzo, F
  • Gasperoni, S
  • Papaldo, P
  • Bilancia, D
  • Manzione, L
  • Landucci, E
  • Mazzoni, F
  • Cognetti, F
Type
Published Article
Journal
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Publication Date
Jan 01, 2006
Volume
17
Issue
1
Pages
79–84
Identifiers
PMID: 16284056
Source
Medline
License
Unknown

Abstract

Weekly paclitaxel plus capecitabine is a safety and active chemotherapy in previously treated metastatic breast cancer.

Report this publication

Statistics

Seen <100 times